Remedy Meds GLP-1 Weight Loss 2026: Pricing, the FDA Compounding Shakeup, and What to Know Before You Commit to a Monthly Plan

LOS ANGELES, March 28, 2026 (Newswire.com) - Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription treatments that should only be used under the supervision of a licensed healthcare provider. Always consult a qualified healthcare professional before starting any prescription treatment. Compounded GLP-1 medications are not FDA-approved finished drug products. Eligibility, prescribing, and treatment decisions must be made by a licensed clinician. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

Important Regulatory Context: Both semaglutide and tirzepatide have been removed from the FDA's drug shortage list. With those shortages now resolved, the regulatory landscape for compounded GLP-1 medications is evolving. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products, and patients should understand that distinction before enrolling in any program. Discuss compounded versus FDA-approved options with a licensed clinician before making any treatment decisions.

RemedyMeds Review 2026: Everything You Need To Know About Compounded Semaglutide and Tirzepatide

If you have been researching GLP-1 weight loss medications online, there is a good chance Remedy Meds has come up in your search results. The platform operates in the direct-to-consumer telehealth weight loss space and offers compounded GLP-1 programs on a month-to-month basis.

But here is the thing most articles about this platform do not cover well: the regulatory landscape around compounded GLP-1 medications shifted dramatically in 2025, and that matters for anyone considering enrollment in 2026. The GLP-1 telehealth market has gotten crowded fast. Some platforms offer compounded semaglutide, others offer compounded tirzepatide, and the pricing, clinical oversight, and regulatory positioning vary considerably from one provider to the next.

This article walks through how Remedy Meds works - the three-entity structure behind every prescription, what the company says about pricing and process, the intake-to-delivery workflow, and the considerations you should weigh before making a decision. All program details, pricing, and claims described below are stated as presented by the company and should be verified directly on the official website before any enrollment decision.

View the current Remedy Meds offer (official Remedy Meds page)

This advertorial is intended for informational purposes and should not be interpreted as a recommendation or endorsement of any specific treatment. Treatment decisions must be made in consultation with a licensed healthcare provider. This content is based on publicly available information and should be verified directly with Remedy Meds and a licensed healthcare provider before making any treatment decision.

Understanding the Compounding Landscape in 2026: What Has Changed

Before evaluating any compounded GLP-1 telehealth platform, it is important to understand the current regulatory environment. This context applies to Remedy Meds and every other company offering compounded semaglutide or tirzepatide.

Compounded medications are not reviewed or approved by the FDA as finished products. They are prepared by licensed pharmacies using active ingredients under the direction of a prescribing clinician. This is a critical distinction from FDA-approved brand-name medications like Ozempic, Wegovy, Mounjaro, and Zepbound.

According to the FDA, the shortage of tirzepatide injection was determined to be resolved in October 2024, and the shortage of semaglutide injection was determined to be resolved in February 2025. The FDA established enforcement discretion periods for compounding pharmacies - with various deadlines through mid-2025 - after which compounders could generally no longer rely on the shortage exception to produce "essentially a copy" of these FDA-approved drugs.

However, under federal compounding law, pharmacies may still compound medications that are not "essentially a copy" of a commercially available drug - for example, formulations with different dosages, added ingredients, or other clinically meaningful modifications that a prescriber determines produce a significant difference for an individual patient. Several telehealth companies, including some of the largest in the space, have continued to offer compounded GLP-1 medications under these frameworks.

Both Eli Lilly (maker of tirzepatide) and Novo Nordisk (maker of semaglutide) have publicly stated their opposition to continued compounding of their products. Legal challenges from the Outsourcing Facilities Association against the FDA's shortage determinations were ultimately denied. The regulatory and legal landscape continues to evolve. Third-party sources are provided for general industry context and do not constitute endorsements. For broader context on how regulatory scrutiny is reshaping the GLP-1 telehealth industry, recent reporting examines the legal and compliance dynamics facing multiple platforms in this space.

What this means for you: If you are considering any compounded GLP-1 program - Remedy Meds or otherwise - you should understand that compounded versions have not undergone FDA premarket review for safety, effectiveness, or quality as finished products. Discuss the distinction between compounded and FDA-approved GLP-1 medications with your healthcare provider before making a decision.

How Remedy Meds Actually Works: The Three-Entity Structure

Like most telehealth weight loss platforms, Remedy Meds operates through a three-entity structure that separates the technology platform, the clinical decision-making, and the medication dispensing. Understanding this structure is important because it affects who is responsible for what in your care.

Remedy Meds LLC (The Platform) functions as the telehealth platform facilitating connections between patients and healthcare providers. According to the company's terms of service, Remedy Meds itself "does not engage in the practice of medicine or provide any other health services." The platform provides the technology infrastructure, customer service, membership management, and coordination that enables the telehealth experience. Remedy Meds is described in its terms as a Delaware limited liability company.

Licensed Medical Providers (Independent Clinicians) are independent healthcare professionals who review patient information and determine whether prescriptions are appropriate. According to the company's terms of service, Remedy Meds provides administrative services on behalf of multiple professional corporations, including entities such as OpenLoop Healthcare Partners and several affiliated professional entities across multiple states. These providers make clinical decisions based on the health information patients provide. The platform does not guarantee that any individual will receive a prescription, as that determination rests entirely with the evaluating clinician.

Licensed U.S. Compounding Pharmacies fulfill prescriptions written by the medical providers. According to the company's website, medications are sourced exclusively from licensed U.S. pharmacies. The platform states that every batch passes four independent tests - potency, sterility, pH, and endotoxicity - before shipping.

This three-entity structure is common across telehealth platforms and ensures appropriate separation between the technology platform, clinical decision-making, and medication dispensing. Remedy Meds is not itself the treating medical provider; it facilitates access to telehealth services and pharmacy fulfillment.

Remedy Meds Pricing: What the Company Says You Pay

Pricing transparency matters in this space - and it is one of the first things people look for. Here is what the company has publicly referenced as of March 2026, though pricing in this category changes frequently and should always be verified directly on the official Remedy Meds website before enrolling.

Compounded Semaglutide Plan: The company has publicly referenced pricing in the range of approximately $299 per month for its compounded semaglutide program. This is a compounded GLP-1 program - distinct from FDA-approved finished drug products like Wegovy or Ozempic. The company positions this as the recommended starting point for people new to GLP-1 medications.

Compounded Tirzepatide Plan: The company has publicly referenced pricing in the range of approximately $399 per month for its compounded tirzepatide program. This is a compounded GLP-1 program - distinct from FDA-approved finished drug products like Zepbound or Mounjaro. The company positions it as a dual GIP/GLP-1 option for people who have hit a weight loss plateau or want a different approach.

GLP-1 Microdose Plan: The company also lists a microdose option - described as a lower dose administered twice weekly. Specific microdose pricing should be verified on the official website, as the company introduced this option more recently.

Branded Medications: According to the company's website, Remedy Meds also lists branded GLP-1 medications such as Ozempic and Zepbound, though availability is described as limited and subject to change.

According to publicly available information, Remedy Meds operates on a month-to-month basis with no long-term contract. The company's terms of service state that cancellation requires 48 hours' notice before the next renewal date. The monthly fee is described as including the medication, clinician consultations, and shipping. The company presents its pricing as consistent regardless of dosage, though patients should confirm how dosing adjustments are handled within their specific plan.

The company describes itself as cash-pay only and does not accept insurance. According to the terms of service, "The Company is cash pay only and the Company does not accept insurance." However, the company's website indicates that HSA and FSA cards may be accepted as payment. Coverage varies by plan administrator, and you should verify HSA/FSA eligibility with your specific plan before purchasing.

Important pricing context: For comparison purposes, brand-name Wegovy injection has a list price that can exceed $1,300 per month without insurance, and brand-name Zepbound has a list price exceeding $1,000 per month without insurance. However, both manufacturers have launched savings programs and direct-to-consumer pricing options in 2025-2026 that have brought some cash-pay costs down significantly. Always compare current pricing across multiple options - including manufacturer savings programs, insurance coverage, and multiple telehealth providers - before committing to any program. Verify current pricing directly on the official Remedy Meds website before making any purchase decision, as pricing in this space changes frequently.

View the current Remedy Meds offer (official Remedy Meds page)

The Intake and Enrollment Process

According to the company's website, the Remedy Meds process works as follows:

Step 1: Online Health Assessment. The company describes this as a questionnaire that takes approximately 90 seconds and covers medical history, weight-related goals, and current medications. According to the company, the assessment is "100% private" and free to complete.

Step 2: Clinician Review. According to the company, a licensed clinician reviews your information and builds a personalized treatment plan. The company's telehealth consent form indicates that the evaluating provider may be a physician, nurse practitioner, or physician assistant depending on your state and assignment. An important note: according to the company's terms, the platform cannot guarantee that any individual will receive a prescription - the clinical determination rests with the evaluating provider.

Step 3: Medication Delivery. After prescription approval, the company states that medication ships from licensed U.S. compounding pharmacies with free, discreet shipping. Shipping timing varies - the company's website references different timeframes in different sections, so verify current fulfillment timelines directly with Remedy Meds after enrollment.

Step 4: Ongoing Care. The company describes monthly clinician check-ins with dosage adjustments as needed, simple refills through a patient dashboard, and the ability to pause, adjust, or cancel at any time. The platform also advertises unlimited video calls and messaging between check-ins.

According to the company's terms of service, the program membership includes "unlimited access to the Remedy Meds online community and resources, unlimited consultations with a licensed clinician, a prescription for GLP-1 medication (if deemed eligible by the clinician), and compounded medication equivalent to four weeks of supply, shipped to your home upon completion of the required monthly refill form."

A critical detail from the terms: According to the company's terms, medication is shipped "upon completion of the required monthly refill form." This means the billing cycle (every 28 days) runs independently of when you request your refill. If you do not complete the refill form, the company's subscription billing continues. Multiple consumer reviews have noted this distinction - the platform charges on a recurring 28-day cycle regardless of whether medication has been requested or shipped. Review the cancellation and refund terms carefully before enrolling.

What GLP-1 Medications Are and How They Work

GLP-1 receptor agonists are a class of prescription medications that mimic a naturally occurring hormone called glucagon-like peptide-1. This hormone plays a role in regulating appetite, blood sugar, and digestion. When GLP-1 receptor agonists are administered, they may help reduce appetite and food intake, slow gastric emptying so you feel full longer, and improve blood sugar regulation.

Semaglutide is a GLP-1 receptor agonist. It is the active ingredient in the FDA-approved brand-name medications Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition). In clinical trials, participants taking semaglutide lost approximately 15% of their body weight on average, compared to about 2.4% in the placebo group.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is the active ingredient in the FDA-approved brand-name medications Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management). In clinical trials, participants taking tirzepatide lost approximately 21% of their body weight on average, compared to about 3.1% in the placebo group. The dual-receptor mechanism targets both hunger and insulin pathways. For additional perspective on how compounded GLP-1 telehealth platforms compare on pricing and FDA regulatory status, recent consumer research reports provide broader market context.

Important distinction: These clinical trial results are from studies of FDA-approved brand-name formulations, not compounded versions. Compounded semaglutide and compounded tirzepatide are prepared by compounding pharmacies and are not FDA-approved finished drug products. They have not been individually reviewed by the FDA for safety, effectiveness, or quality as finished products. Compounded GLP-1 programs are distinct from the FDA-approved medications used in these trials. The evaluating clinician determines whether a compounded option is appropriate based on individual health factors.

GLP-1 medications carry serious risks, including risks of thyroid C-cell tumors (including thyroid cancer) and medullary thyroid carcinoma (MTC). According to FDA labeling, these medications are contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2. Common side effects may include nausea, vomiting, diarrhea, constipation, and abdominal pain. These medications should only be used under the supervision of a licensed healthcare professional.

Who the Remedy Meds Program May Be Right For

Remedy Meds May Align Well With People Who:

Prefer month-to-month flexibility without a long-term commitment: According to the company, the platform operates on a monthly basis with 48-hour cancellation notice. If you want to try GLP-1 treatment without locking into a long-term plan, the month-to-month structure may fit your situation.

Want pricing that the company says stays consistent as dosage changes: According to the company, Remedy Meds presents its pricing as a flat monthly rate regardless of whether your dose increases over time. Some platforms in this space charge more as dosage escalates, which can create unexpected cost increases several months into treatment. Confirm how dosing adjustments are handled within your specific plan before relying on this feature.

Value access to clinician support between scheduled check-ins: The company advertises unlimited video calls and messaging with your care team, plus a member community. If ongoing clinical access and community support matter to your experience, these features may be relevant to your decision.

Are cash-pay patients looking for compounded GLP-1 access: If you do not have insurance coverage for brand-name GLP-1 medications and the out-of-pocket cost for Wegovy or Zepbound exceeds your budget, compounded options through platforms like Remedy Meds represent an alternative price point - though with the important trade-off that compounded medications have not undergone FDA premarket review as finished products.

Other Options May Be Preferable For People Who:

Have insurance coverage for brand-name GLP-1 medications: If your insurance covers Wegovy, Zepbound, Ozempic, or Mounjaro - or if you qualify for manufacturer savings programs - the FDA-approved versions may be a better fit. FDA-approved drugs have undergone rigorous review for safety, effectiveness, and quality. Always explore insurance and manufacturer discount options first.

Prefer FDA-approved medications exclusively: If you are uncomfortable with the compounded medication distinction, or if the evolving regulatory landscape around compounded GLP-1s concerns you, platforms offering FDA-approved brand-name medications may better match your comfort level. Several telehealth platforms now offer brand-name GLP-1 access, some at recently reduced manufacturer pricing.

Want an oral medication option: According to available information, Remedy Meds primarily offers injectable GLP-1 medications. If you prefer oral tablets over injections, other platforms or the new oral semaglutide options (Wegovy pill, Rybelsus) may be worth exploring. Verify current oral availability directly with Remedy Meds, as offerings in this space change frequently.

Are in a state with limited availability: Service availability may vary by state. The company's terms of service reference availability in all 50 states plus the District of Columbia, while some independent sources report that certain states may be excluded. Verify state availability directly with the company before beginning the intake process.

Questions to Ask Yourself

Before choosing any GLP-1 telehealth platform, consider these questions. Your answers help determine which program characteristics matter most for your specific situation:

Have I explored whether my insurance covers FDA-approved GLP-1 medications? Have I checked manufacturer savings programs for brand-name options? Am I comfortable with the distinction between compounded and FDA-approved medications? Have I discussed GLP-1 treatment with my primary care physician? Do I understand the billing cycle and cancellation terms? What level of clinical support do I need between appointments? Am I prepared for the potential side effects of GLP-1 medications? Have I reviewed the current regulatory status of compounded GLP-1 medications?

What Remedy Meds Says About Member Outcomes

The following claims are attributed entirely to Remedy Meds and are based on self-reported data from the company's member population. They should not be interpreted as guaranteed or typical outcomes for every patient.

According to Remedy Meds, members on its personalized treatment plans have reported results such as an average of 45 lbs lost in the first 6 months on the semaglutide plan, 50 lbs lost in the first 6 months on the tirzepatide plan, and "top responders" losing 65 lbs and 76 lbs respectively in 12 months. The company also states a 94.6% success rate (defined as members losing 5% or more of their body weight).

Remedy Meds' own disclosure, stated directly on the company's website: "Results are based on self-reported data from ~300,000 Remedy Meds members on personalized treatment plans, including compounded GLP-1 medications and clinician consultations. Members reported their weight on their initial medical intake questionnaire and every 3-4 weeks thereafter. Individual results may vary." The company also states that "members were compensated for their testimonials."

What you should know when evaluating these figures: Self-reported data from an active member population has inherent limitations. Members who continue with the program and report results are likely those experiencing positive outcomes - people who discontinue treatment or are dissatisfied are less likely to continue reporting data. This is known as survivorship bias. These figures should not be read as guaranteed outcomes for every enrollee. Individual results vary significantly based on starting weight, adherence, lifestyle factors, and other health variables.

The company also advertises a "365-Day Money-Back Guarantee" described as a "Weight Loss Warranty." According to the company's website, terms and conditions apply to this guarantee. The company's standard terms of service state that "Once paid, your Program Membership Fee is non-refundable." Review the specific weight loss warranty terms directly with the company before enrolling, as the guarantee terms and the standard refund policy may differ. Understand the exact conditions, timeline, and process for any refund before committing.

Safety Considerations for GLP-1 Medications

GLP-1 medications are prescription drugs that carry significant safety considerations. The following is a high-level overview, not a complete list of risks or precautions. Always review the full safety information provided with your prescription and consult your prescriber or pharmacist with any questions.

Serious risks: According to FDA labeling for semaglutide and tirzepatide, these medications carry boxed warnings for thyroid C-cell tumors. In animal studies, GLP-1 receptor agonists caused thyroid C-cell tumors, including medullary thyroid carcinoma. It is unknown whether these medications cause thyroid C-cell tumors, including MTC, in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Common side effects reported in clinical trials include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, and abdominal distension. Nausea is typically most common during dose escalation periods.

Additional considerations: Pancreatitis has been reported with GLP-1 receptor agonists. Gallbladder-related events, including cholelithiasis and cholecystitis, have been reported. Hypoglycemia risk increases when used with insulin or insulin secretagogues. Kidney injury has been reported, sometimes in association with dehydration from gastrointestinal side effects. Suicidal behavior and ideation have been reported in post-marketing surveillance. If you experience severe abdominal pain, symptoms of pancreatitis, or any concerning symptoms, contact your healthcare provider immediately.

Compounding-specific considerations: The FDA has noted that it has received adverse event reports associated with compounded semaglutide and compounded tirzepatide, including reports of dosing errors. Some of these errors resulted from patients measuring and self-administering incorrect doses. Follow all injection instructions provided by your prescriber and pharmacist carefully.

This safety overview is not exhaustive and does not replace official prescribing information. Always consult your healthcare provider before starting any GLP-1 medication, especially if you have existing health conditions, take other medications, are pregnant or nursing, or have any questions about treatment.

How Remedy Meds Compares in the GLP-1 Telehealth Market

The GLP-1 telehealth space has many providers competing for patients. Rather than making comparative claims about which platform is "best" - which would require independent market data we do not have - here is a framework for evaluating any GLP-1 telehealth provider, including Remedy Meds:

Pricing structure: Does the platform charge per month or require multi-month commitments? Does pricing increase with dosage? What is included in the monthly fee (medication, consultations, shipping)? Are there hidden fees? How does the platform's pricing compare to current manufacturer cash-pay options for brand-name medications?

Clinical oversight: Who evaluates your case - physicians, nurse practitioners, or physician assistants? How are follow-up appointments structured? Is there access to a licensed clinician between scheduled visits? Does the platform require lab work or health screenings before prescribing?

Medication sourcing: Where are compounded medications sourced from? What quality testing does the pharmacy perform? Does the platform disclose its pharmacy partners? Does the platform offer FDA-approved brand-name options in addition to compounded versions?

Cancellation and refund policies: How much notice is required to cancel? Are payments refundable? What happens to medication access if you cancel mid-cycle? How does the billing cycle relate to medication shipments?

Regulatory positioning: How is the company addressing the post-shortage regulatory landscape for compounded GLP-1s? Is the company offering "personalized" formulations, and what does that mean in practice? How transparent is the company about the compounded vs. FDA-approved distinction?

We encourage you to evaluate multiple providers using these criteria before making a decision. No single platform is right for everyone, and the best choice depends on your insurance status, budget, medical history, and comfort level with compounded medications.

View the current Remedy Meds offer (official Remedy Meds page)

What Consumer Feedback Looks Like: A Balanced Perspective

Remedy Meds publishes customer reviews on its website and has reviews on third-party platforms including Trustpilot and ConsumerAffairs. As with any platform, it is important to approach reviews with an understanding that people who write reviews are self-selected - satisfied customers and very dissatisfied customers are both more likely to leave reviews than those with neutral experiences.

According to ConsumerAffairs, which includes verified reviews, Remedy Meds has a mix of experiences. The company's Trustpilot profile shows a rating of 4.7 according to the company's website. The company also states it has served over 250,000 members.

Without reproducing specific reviews, some publicly available feedback suggests themes such as appreciation for the straightforward intake process, the flat pricing structure, and clinical support availability. Some publicly available reviews also raise concerns about billing cycle confusion (charges continuing when refill forms are not completed), difficulty obtaining refunds, and occasional issues with shipping delays or customer service responsiveness.

These patterns are not unique to Remedy Meds - billing and customer service concerns are common across the GLP-1 telehealth industry. However, given that this is a subscription service with recurring charges, reviewing the terms of service and understanding the billing mechanics is especially important before enrolling.

Contact Information

For questions before or during enrollment, according to the company's website, Remedy Meds offers customer support through the following channels:

Phone: +1 (551) 239-9025
Hours: 7 days a week, 8:00 AM - 8:00 PM Eastern Time
Email: support@remedymeds.com
Help Center: help.remedymeds.com

View the current Remedy Meds offer (official Remedy Meds page)

Final Verdict: The Case for Remedy Meds - and the Considerations to Weigh

The case for Remedy Meds: The platform offers a month-to-month approach to compounded GLP-1 access with flat pricing that, according to the company, does not increase with dosage. The company advertises unlimited clinician access, community support, and a structured care plan. For cash-pay patients who do not have insurance coverage for brand-name GLP-1 medications, the program may represent a lower monthly price point than brand-name list prices - though that gap has narrowed as manufacturers have introduced their own savings programs and direct-to-consumer pricing in 2025-2026.

Considerations to weigh: Compounded medications have not undergone FDA premarket review as finished products - this is a fundamental trade-off of any compounded GLP-1 program. The regulatory landscape around compounded GLP-1 medications continues to evolve following the resolution of the semaglutide and tirzepatide shortages, and the long-term availability of these compounded options is uncertain. The company's billing structure requires attention - the 28-day subscription cycle runs independently of medication refill requests, and the standard terms describe payments as non-refundable. The weight loss warranty advertised on the website should be reviewed in detail, as its terms may differ from the standard refund policy.

Important Note: The GLP-1 telehealth and compounded medication space has been under significant regulatory scrutiny in recent years, particularly following the FDA's determinations that semaglutide and tirzepatide shortages have been resolved. Both drug manufacturers and federal regulators have raised questions about the continued compounding of these medications. Consumers should review the most current information about any platform's regulatory compliance, medication quality, and legal standing before proceeding with treatment.

This is not a replacement for professional medical advice. Only a licensed clinician can determine whether GLP-1 treatment is appropriate for your specific situation. Talk through all of your options - FDA-approved brand-name medications, manufacturer savings programs, insurance pathways, and compounded alternatives - with your healthcare provider before starting any weight loss medication.

What to Verify Before You Enroll in Any GLP-1 Telehealth Program

This checklist applies to Remedy Meds and every other compounded GLP-1 platform. Before you commit to any program, take 15 minutes and work through these items. Your future self will thank you.

Check your insurance first. Before paying cash for a compounded option, find out whether your health plan covers FDA-approved GLP-1 medications like Wegovy or Zepbound. Also check whether manufacturer savings programs or patient assistance programs could reduce your out-of-pocket cost. You may have options you do not know about.

Understand what "compounded" actually means. Compounded GLP-1 medications are not FDA-approved finished drug products. They are prepared by licensed pharmacies under the direction of a prescribing clinician. This is a meaningful distinction from brand-name medications that have gone through FDA review for safety, effectiveness, and quality. Make sure you are comfortable with that trade-off before enrolling.

Read the cancellation and refund terms - the actual terms, not the marketing. Pay close attention to how billing cycles work, what triggers a charge, and what the refund policy says in the fine print. For Remedy Meds specifically, note that the 28-day billing cycle operates independently of whether you have requested a medication refill.

Ask who will actually be evaluating your case. Will it be a physician, a nurse practitioner, or a physician assistant? This can vary by state and by platform. Understanding who is making your clinical decisions matters.

Verify current pricing the day you enroll. Pricing in the GLP-1 telehealth space changes frequently. Do not rely on pricing from articles, social media ads, or even the company's own marketing materials from a month ago. Check the checkout page the same day you plan to enroll.

Ask about the regulatory status of the specific product you would receive. With compounded GLP-1 shortages resolved, the legal framework under which platforms can offer these medications is evolving. Ask your provider how the program is positioned under current compounding regulations.

View the current Remedy Meds offer (official Remedy Meds page)

Frequently Asked Questions

Is Remedy Meds a healthcare provider?

According to the company's terms of service, Remedy Meds is not itself a healthcare provider. The company functions as a telehealth platform that facilitates connections between patients and independent licensed clinicians who make prescribing decisions. The company provides the technology, customer service, and coordination infrastructure.

Are Remedy Meds medications FDA-approved?

Remedy Meds primarily offers compounded semaglutide and compounded tirzepatide. Compounded medications are not reviewed or approved by the FDA as finished products. They are prepared by licensed pharmacies using active ingredients under the direction of a prescribing clinician. The company also lists branded FDA-approved medications with limited availability.

What is the difference between compounded and brand-name GLP-1 medications?

Brand-name medications like Wegovy, Ozempic, Zepbound, and Mounjaro are manufactured by pharmaceutical companies and have undergone FDA review for safety, effectiveness, and quality. Compounded versions are prepared by compounding pharmacies and are not FDA-approved finished drug products - they have not undergone that same FDA premarket review. Compounded GLP-1 programs are distinct from FDA-approved medications. The evaluating clinician determines whether a compounded option is appropriate based on individual health factors.

What is the cancellation policy?

According to the company's terms of service, cancellation requires 48 hours' notice before the next renewal date. Once paid, the program membership fee for the current subscription term is described as non-refundable. You will continue to have access to services through the end of your paid term. Review the full terms of service before enrolling.

Does Remedy Meds accept insurance?

According to the company's terms of service, Remedy Meds is cash-pay only and does not accept insurance. The company's website indicates that HSA and FSA cards may be accepted. Verify HSA/FSA eligibility with your specific plan administrator before purchasing.

What states does Remedy Meds serve?

According to the company's terms of service, the services are available in all 50 states plus the District of Columbia. However, some independent sources report that certain states may be excluded for specific services. Verify availability for your state directly through the company's intake process.

What happens if I do not lose weight?

The company advertises a "365-Day Money-Back Guarantee" described as a "Weight Loss Warranty" with terms and conditions. Separately, the standard terms of service describe program membership fees as non-refundable. Review the specific warranty terms, conditions, and process directly with the company before relying on this guarantee.

Disclaimers

Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The descriptions of potential benefits are not guarantees and are not a substitute for an individualized medical evaluation. GLP-1 medications are prescription drugs that require evaluation by a licensed clinician. The information provided here does not replace the professional judgment of your healthcare provider.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. GLP-1 medications are not a substitute for prescribed medical treatment for obesity or any other health condition. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any GLP-1 medication or new prescription treatment. Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's guidance and approval.

Compounded Medication Notice: Remedy Meds offers compounded GLP-1 medications prepared by licensed pharmacies based on individual prescriptions. Compounded medications are not reviewed or approved by the FDA as finished products. They are prepared using active ingredients under the direction of a prescribing clinician. Unlike FDA-approved drugs, compounded medications are not reviewed by the FDA for safety, effectiveness, or quality before they are dispensed; they are prepared by pharmacies under federal and state compounding rules. The evaluating clinician determines whether this option is appropriate based on individual health factors.

Results May Vary: Individual results will vary based on factors including age, starting weight, baseline health condition, lifestyle factors, consistency of use, genetic factors, current medications, diet, exercise habits, and other individual variables. The outcome data cited in this article is based on self-reported data from the company's member population and should not be interpreted as guaranteed or typical results. People who continue with a program and report results are self-selected - satisfied participants are more likely to continue reporting than those with neutral or negative experiences.

FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on publicly available information from the company's official website, terms of service, and independent third-party sources.

Pricing Disclaimer: All prices, plan structures, and promotional offers mentioned were based on publicly available information at the time of publication (March 2026) but are subject to change without notice. The GLP-1 telehealth market is evolving rapidly, with pricing changes occurring frequently across the industry. Always verify current pricing and terms on the official Remedy Meds website before making your purchase.

Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with Remedy Meds, their healthcare provider, and relevant regulatory resources before making decisions.

Insurance Coverage Note: Remedy Meds is described as a cash-pay service that does not accept insurance. Many direct-to-consumer GLP-1 programs are not covered by traditional insurance plans. However, coverage for FDA-approved brand-name GLP-1 medications varies by plan. HSA/FSA eligibility for compounded medications varies by plan administrator. Always explore all coverage options - including insurance, manufacturer savings programs, and patient assistance programs - before committing to a cash-pay program.

Regulatory Context Notice: The regulatory landscape for compounded GLP-1 medications is evolving. The FDA has determined that shortages of both semaglutide and tirzepatide have been resolved, which affects the legal framework under which compounding pharmacies can produce these medications. The long-term availability of compounded GLP-1 options is uncertain and may be affected by ongoing regulatory actions and legal proceedings. This article does not provide legal advice regarding the regulatory status of any product or company.

SOURCE: RemedyMeds

Source: RemedyMeds